{
  "trial_id": "NCT02545907",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Aged 18 years or greater",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Diagnosis of systemic AL amyloidosis",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Amyloid related organ dysfunction or organ syndrome",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Measurable clonal disease",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Clonal relapse after previous chemotherapy or stem cell transplant OR refractory to previous chemotherapy or stem cell transplant",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has systemic AL amyloidosis and is on hemodialysis for ESRD. She was treated with melphalan and prednisone, followed by VAD regimen, and autologous stem cell transplant.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT02545907",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}